Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Skin Neoplasms | 25 | 2024 | 5815 | 1.530 |
Why?
|
Melanoma | 32 | 2022 | 5704 | 1.480 |
Why?
|
Proto-Oncogene Proteins B-raf | 14 | 2018 | 2052 | 0.970 |
Why?
|
Lichen Sclerosus et Atrophicus | 2 | 2020 | 28 | 0.850 |
Why?
|
Sweat Gland Neoplasms | 4 | 2013 | 116 | 0.850 |
Why?
|
Carcinoma, Squamous Cell | 12 | 2024 | 4020 | 0.730 |
Why?
|
Balanitis Xerotica Obliterans | 1 | 2020 | 2 | 0.710 |
Why?
|
Penile Neoplasms | 7 | 2020 | 161 | 0.630 |
Why?
|
Precancerous Conditions | 4 | 2020 | 978 | 0.630 |
Why?
|
Ubiquitin Thiolesterase | 3 | 2015 | 455 | 0.560 |
Why?
|
Skin | 7 | 2021 | 4474 | 0.480 |
Why?
|
Dermatomycoses | 2 | 2011 | 48 | 0.420 |
Why?
|
Coccidioides | 1 | 2010 | 18 | 0.370 |
Why?
|
Antibodies, Fungal | 1 | 2010 | 34 | 0.370 |
Why?
|
Coccidioidomycosis | 1 | 2010 | 37 | 0.360 |
Why?
|
Acrospiroma | 1 | 2010 | 11 | 0.360 |
Why?
|
Nevus, Pigmented | 4 | 2015 | 221 | 0.360 |
Why?
|
Leprostatic Agents | 1 | 2010 | 14 | 0.360 |
Why?
|
Tumor Suppressor Proteins | 4 | 2015 | 2803 | 0.360 |
Why?
|
Melanocytes | 4 | 2014 | 509 | 0.340 |
Why?
|
Leprosy | 1 | 2010 | 125 | 0.340 |
Why?
|
Protein Kinase Inhibitors | 6 | 2018 | 5662 | 0.330 |
Why?
|
Fusarium | 1 | 2009 | 51 | 0.330 |
Why?
|
Lung Diseases, Fungal | 1 | 2009 | 126 | 0.310 |
Why?
|
Neoplasm Metastasis | 7 | 2016 | 4903 | 0.300 |
Why?
|
Nevus, Epithelioid and Spindle Cell | 3 | 2014 | 70 | 0.270 |
Why?
|
Indoles | 8 | 2016 | 1833 | 0.270 |
Why?
|
Opportunistic Infections | 1 | 2009 | 376 | 0.270 |
Why?
|
Lymphatic Metastasis | 5 | 2013 | 2912 | 0.260 |
Why?
|
Sulfonamides | 9 | 2016 | 1973 | 0.250 |
Why?
|
Immunohistochemistry | 18 | 2017 | 11070 | 0.250 |
Why?
|
Neoplastic Stem Cells | 2 | 2018 | 1347 | 0.250 |
Why?
|
MAP Kinase Signaling System | 5 | 2016 | 1485 | 0.230 |
Why?
|
Carcinoma, Basal Cell | 2 | 2021 | 559 | 0.210 |
Why?
|
Cell Proliferation | 4 | 2014 | 10425 | 0.210 |
Why?
|
Neoplasm Staging | 5 | 2023 | 11096 | 0.200 |
Why?
|
Sentinel Lymph Node Biopsy | 3 | 2012 | 732 | 0.200 |
Why?
|
Melanins | 1 | 2003 | 289 | 0.190 |
Why?
|
Mutation | 8 | 2020 | 30025 | 0.190 |
Why?
|
Neoplasm Invasiveness | 6 | 2023 | 3587 | 0.190 |
Why?
|
Mitotic Index | 2 | 2012 | 161 | 0.180 |
Why?
|
Gene Expression Regulation, Neoplastic | 4 | 2018 | 8519 | 0.180 |
Why?
|
Mohs Surgery | 2 | 2021 | 222 | 0.180 |
Why?
|
Keratosis, Actinic | 1 | 2021 | 72 | 0.170 |
Why?
|
Carcinoma in Situ | 2 | 2019 | 791 | 0.170 |
Why?
|
Drug Resistance, Neoplasm | 6 | 2018 | 5292 | 0.170 |
Why?
|
Chromosomal Proteins, Non-Histone | 2 | 2022 | 726 | 0.160 |
Why?
|
Retinoid X Receptor gamma | 1 | 2018 | 3 | 0.160 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2024 | 973 | 0.150 |
Why?
|
Polyomavirus Infections | 1 | 2020 | 194 | 0.150 |
Why?
|
Leukemia, Myeloid, Acute | 2 | 2014 | 3610 | 0.150 |
Why?
|
Keratin-6 | 2 | 2014 | 18 | 0.150 |
Why?
|
Keratin-5 | 2 | 2014 | 45 | 0.140 |
Why?
|
Biopsy | 7 | 2021 | 6765 | 0.140 |
Why?
|
Tumor Virus Infections | 1 | 2020 | 438 | 0.140 |
Why?
|
Scleroderma, Localized | 1 | 2017 | 87 | 0.140 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2024 | 1766 | 0.140 |
Why?
|
Humans | 65 | 2024 | 760437 | 0.140 |
Why?
|
GATA3 Transcription Factor | 2 | 2014 | 152 | 0.130 |
Why?
|
Penis | 3 | 2019 | 212 | 0.130 |
Why?
|
Prognosis | 9 | 2023 | 29551 | 0.130 |
Why?
|
Antigens, Nuclear | 1 | 2016 | 184 | 0.130 |
Why?
|
Carcinoma, Merkel Cell | 1 | 2020 | 328 | 0.130 |
Why?
|
Receptors, Platelet-Derived Growth Factor | 1 | 2015 | 178 | 0.120 |
Why?
|
Diagnosis, Differential | 7 | 2013 | 12969 | 0.120 |
Why?
|
Janus Kinase 1 | 1 | 2015 | 107 | 0.120 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 3 | 2014 | 1089 | 0.120 |
Why?
|
Niacinamide | 2 | 2014 | 413 | 0.120 |
Why?
|
Adenocarcinoma, Clear Cell | 1 | 2016 | 217 | 0.120 |
Why?
|
Male | 36 | 2024 | 360035 | 0.120 |
Why?
|
Maxillary Sinus Neoplasms | 1 | 2014 | 39 | 0.120 |
Why?
|
Myositis | 1 | 2017 | 271 | 0.120 |
Why?
|
Adenocarcinoma | 3 | 2014 | 6330 | 0.120 |
Why?
|
Dysplastic Nevus Syndrome | 2 | 2011 | 61 | 0.110 |
Why?
|
NF-kappa B p50 Subunit | 1 | 2014 | 103 | 0.110 |
Why?
|
Molecular Targeted Therapy | 2 | 2015 | 2805 | 0.110 |
Why?
|
Phenylurea Compounds | 2 | 2014 | 528 | 0.110 |
Why?
|
Antineoplastic Agents | 4 | 2015 | 13616 | 0.110 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2016 | 9267 | 0.110 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 2 | 2013 | 641 | 0.110 |
Why?
|
Rhabdomyosarcoma, Embryonal | 1 | 2014 | 100 | 0.110 |
Why?
|
Neoplasm, Residual | 1 | 2018 | 1008 | 0.110 |
Why?
|
Groin | 1 | 2013 | 106 | 0.110 |
Why?
|
Melanoma-Specific Antigens | 1 | 2013 | 74 | 0.110 |
Why?
|
Dog Diseases | 1 | 2013 | 141 | 0.110 |
Why?
|
Disease-Free Survival | 1 | 2023 | 6813 | 0.100 |
Why?
|
Sweet Syndrome | 1 | 2013 | 58 | 0.100 |
Why?
|
Granuloma Annulare | 1 | 2013 | 29 | 0.100 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 1 | 2015 | 664 | 0.100 |
Why?
|
Conjunctivitis | 1 | 2013 | 155 | 0.100 |
Why?
|
Cell Line, Tumor | 12 | 2017 | 16945 | 0.100 |
Why?
|
Brain Neoplasms | 1 | 2013 | 9003 | 0.100 |
Why?
|
raf Kinases | 1 | 2012 | 118 | 0.100 |
Why?
|
Lymphatic Diseases | 1 | 2013 | 320 | 0.100 |
Why?
|
Oximes | 1 | 2013 | 303 | 0.090 |
Why?
|
Neoplasms, Basal Cell | 1 | 2011 | 31 | 0.090 |
Why?
|
Condylomata Acuminata | 1 | 2011 | 75 | 0.090 |
Why?
|
Dermatology | 2 | 2012 | 916 | 0.090 |
Why?
|
Alternaria | 1 | 2011 | 42 | 0.090 |
Why?
|
Neural Stem Cells | 1 | 2018 | 888 | 0.090 |
Why?
|
fms-Like Tyrosine Kinase 3 | 1 | 2014 | 495 | 0.090 |
Why?
|
Radiography | 2 | 2013 | 6963 | 0.090 |
Why?
|
Herpes Zoster | 1 | 2013 | 253 | 0.090 |
Why?
|
Retrospective Studies | 8 | 2023 | 80430 | 0.090 |
Why?
|
Heat-Shock Proteins | 2 | 2005 | 795 | 0.090 |
Why?
|
Eye Neoplasms | 1 | 2012 | 307 | 0.090 |
Why?
|
Aged | 18 | 2024 | 168840 | 0.090 |
Why?
|
Membrane Proteins | 3 | 2014 | 7849 | 0.090 |
Why?
|
Drug Antagonism | 1 | 2009 | 51 | 0.080 |
Why?
|
Xenograft Model Antitumor Assays | 5 | 2018 | 3590 | 0.080 |
Why?
|
Estrogen Receptor alpha | 1 | 2013 | 581 | 0.080 |
Why?
|
Tumor Escape | 2 | 2014 | 370 | 0.080 |
Why?
|
Middle Aged | 21 | 2024 | 220382 | 0.080 |
Why?
|
Adenoma, Sweat Gland | 1 | 2009 | 17 | 0.080 |
Why?
|
Pathology, Surgical | 1 | 2010 | 151 | 0.080 |
Why?
|
Bone Marrow Examination | 1 | 2009 | 154 | 0.080 |
Why?
|
Trisomy | 1 | 2010 | 260 | 0.080 |
Why?
|
Aged, 80 and over | 9 | 2020 | 58859 | 0.080 |
Why?
|
Receptors, Progesterone | 1 | 2013 | 1128 | 0.080 |
Why?
|
Water | 1 | 2015 | 1409 | 0.080 |
Why?
|
Photochemotherapy | 1 | 2015 | 823 | 0.080 |
Why?
|
Autoantibodies | 1 | 2017 | 2123 | 0.080 |
Why?
|
Mouth Neoplasms | 1 | 2013 | 595 | 0.080 |
Why?
|
In Situ Hybridization, Fluorescence | 2 | 2014 | 2509 | 0.080 |
Why?
|
Pathology, Clinical | 1 | 2012 | 375 | 0.080 |
Why?
|
Hidrocystoma | 1 | 2007 | 11 | 0.080 |
Why?
|
Apocrine Glands | 1 | 2007 | 32 | 0.070 |
Why?
|
Antifungal Agents | 2 | 2011 | 751 | 0.070 |
Why?
|
Genes, ras | 1 | 2010 | 653 | 0.070 |
Why?
|
Nevus | 1 | 2009 | 205 | 0.070 |
Why?
|
Cystadenoma | 1 | 2007 | 79 | 0.070 |
Why?
|
Germ-Line Mutation | 2 | 2015 | 1850 | 0.070 |
Why?
|
Immunocompromised Host | 2 | 2011 | 855 | 0.070 |
Why?
|
Receptors, Androgen | 1 | 2013 | 1077 | 0.070 |
Why?
|
Multiprotein Complexes | 1 | 2013 | 1119 | 0.070 |
Why?
|
Lymph Node Excision | 2 | 2012 | 1273 | 0.070 |
Why?
|
Imidazoles | 1 | 2013 | 1179 | 0.070 |
Why?
|
Cough | 1 | 2010 | 594 | 0.070 |
Why?
|
Cancer Vaccines | 2 | 2005 | 1050 | 0.070 |
Why?
|
Adolescent | 6 | 2020 | 88196 | 0.070 |
Why?
|
Breast Neoplasms | 1 | 2013 | 20985 | 0.070 |
Why?
|
Enzyme Inhibitors | 2 | 2015 | 3710 | 0.070 |
Why?
|
Female | 23 | 2024 | 391875 | 0.060 |
Why?
|
Exanthema | 1 | 2010 | 504 | 0.060 |
Why?
|
Gene Amplification | 1 | 2010 | 1086 | 0.060 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2015 | 1889 | 0.060 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 3 | 2015 | 11729 | 0.060 |
Why?
|
Receptor, erbB-2 | 2 | 2013 | 2553 | 0.060 |
Why?
|
Fever | 1 | 2013 | 1618 | 0.060 |
Why?
|
Hand | 1 | 2011 | 902 | 0.060 |
Why?
|
Sequence Analysis, DNA | 2 | 2013 | 4735 | 0.060 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2017 | 2163 | 0.060 |
Why?
|
Lymphatic System | 1 | 2006 | 254 | 0.060 |
Why?
|
Fatal Outcome | 1 | 2009 | 1832 | 0.060 |
Why?
|
Papillomavirus Infections | 1 | 2016 | 1610 | 0.060 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2013 | 2058 | 0.060 |
Why?
|
MAP Kinase Kinase 1 | 2 | 2018 | 331 | 0.060 |
Why?
|
Chromosome Aberrations | 1 | 2010 | 1771 | 0.060 |
Why?
|
Radiosurgery | 1 | 2013 | 1341 | 0.060 |
Why?
|
Adult | 15 | 2020 | 220781 | 0.050 |
Why?
|
Adipose Tissue | 1 | 2015 | 3306 | 0.050 |
Why?
|
Ki-67 Antigen | 3 | 2011 | 629 | 0.050 |
Why?
|
Neurofibromin 2 | 1 | 2003 | 270 | 0.050 |
Why?
|
Microphthalmia-Associated Transcription Factor | 2 | 2014 | 259 | 0.050 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2005 | 891 | 0.050 |
Why?
|
Nuclear Proteins | 1 | 2016 | 5794 | 0.050 |
Why?
|
Receptors, Immunologic | 1 | 2007 | 1411 | 0.050 |
Why?
|
Bone Marrow Transplantation | 1 | 2009 | 2693 | 0.050 |
Why?
|
Interferon-alpha | 1 | 2005 | 920 | 0.050 |
Why?
|
Carcinoma, Verrucous | 1 | 2001 | 27 | 0.050 |
Why?
|
Lymph Nodes | 2 | 2010 | 3469 | 0.050 |
Why?
|
Lung Diseases | 1 | 2010 | 1909 | 0.040 |
Why?
|
Frozen Sections | 1 | 2021 | 153 | 0.040 |
Why?
|
Tumor Cells, Cultured | 2 | 2018 | 6128 | 0.040 |
Why?
|
Cell Growth Processes | 2 | 2012 | 384 | 0.040 |
Why?
|
Adjuvants, Immunologic | 1 | 2005 | 1035 | 0.040 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2009 | 2821 | 0.040 |
Why?
|
Tumor Microenvironment | 1 | 2013 | 3874 | 0.040 |
Why?
|
T-Lymphocyte Subsets | 1 | 2007 | 1805 | 0.040 |
Why?
|
Apoptosis | 4 | 2013 | 9468 | 0.040 |
Why?
|
Polyomavirus | 1 | 2020 | 234 | 0.040 |
Why?
|
Myelodysplastic Syndromes | 1 | 2009 | 1393 | 0.040 |
Why?
|
Autoantigens | 1 | 2003 | 876 | 0.040 |
Why?
|
Animals | 11 | 2018 | 168253 | 0.040 |
Why?
|
Interferons | 1 | 2022 | 704 | 0.040 |
Why?
|
Cell Cycle Proteins | 2 | 2022 | 3446 | 0.040 |
Why?
|
Biopsy, Needle | 2 | 2015 | 1626 | 0.040 |
Why?
|
Phagocytosis | 1 | 2003 | 1536 | 0.040 |
Why?
|
Child, Preschool | 3 | 2016 | 42209 | 0.040 |
Why?
|
Circumcision, Male | 1 | 2019 | 148 | 0.040 |
Why?
|
Infant | 2 | 2016 | 36183 | 0.040 |
Why?
|
Mice, Nude | 2 | 2015 | 3603 | 0.040 |
Why?
|
HLA Antigens | 1 | 2002 | 1371 | 0.030 |
Why?
|
Down-Regulation | 2 | 2015 | 2911 | 0.030 |
Why?
|
Dual Specificity Phosphatase 6 | 1 | 2016 | 13 | 0.030 |
Why?
|
Practice Guidelines as Topic | 2 | 2011 | 7380 | 0.030 |
Why?
|
Time-Lapse Imaging | 1 | 2017 | 194 | 0.030 |
Why?
|
Neovascularization, Pathologic | 1 | 2007 | 2642 | 0.030 |
Why?
|
Mass Spectrometry | 2 | 2015 | 2189 | 0.030 |
Why?
|
Flow Cytometry | 3 | 2017 | 5865 | 0.030 |
Why?
|
Spheroids, Cellular | 1 | 2017 | 329 | 0.030 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2014 | 4575 | 0.030 |
Why?
|
Human papillomavirus 18 | 1 | 2016 | 125 | 0.030 |
Why?
|
Antigens, Neoplasm | 3 | 2014 | 1994 | 0.030 |
Why?
|
Reproducibility of Results | 4 | 2021 | 20078 | 0.030 |
Why?
|
Young Adult | 2 | 2020 | 59068 | 0.030 |
Why?
|
T-Lymphocytes | 3 | 2007 | 10188 | 0.030 |
Why?
|
Benzocycloheptenes | 1 | 2014 | 9 | 0.030 |
Why?
|
Observer Variation | 1 | 2021 | 2604 | 0.030 |
Why?
|
DNA, Neoplasm | 1 | 2020 | 1745 | 0.030 |
Why?
|
Proto-Oncogenes | 1 | 2015 | 321 | 0.030 |
Why?
|
Human papillomavirus 16 | 1 | 2016 | 267 | 0.030 |
Why?
|
Carcinoma, Transitional Cell | 1 | 2001 | 779 | 0.030 |
Why?
|
Child | 3 | 2020 | 80086 | 0.030 |
Why?
|
Epithelium | 1 | 2019 | 1603 | 0.030 |
Why?
|
HLA-A Antigens | 2 | 2005 | 226 | 0.030 |
Why?
|
Immunocompetence | 1 | 2014 | 138 | 0.030 |
Why?
|
Genome | 1 | 2022 | 1739 | 0.030 |
Why?
|
Ribosomal Protein S6 | 1 | 2013 | 71 | 0.030 |
Why?
|
Porphyrins | 1 | 2015 | 352 | 0.030 |
Why?
|
Vertigo | 1 | 1975 | 202 | 0.030 |
Why?
|
Mice, SCID | 1 | 2018 | 2625 | 0.030 |
Why?
|
Maxillary Sinus | 1 | 2014 | 180 | 0.030 |
Why?
|
DNA, Viral | 1 | 2020 | 2201 | 0.030 |
Why?
|
Immunoprecipitation | 1 | 2015 | 877 | 0.030 |
Why?
|
Combined Modality Therapy | 2 | 2015 | 8522 | 0.030 |
Why?
|
Immunophenotyping | 1 | 2017 | 1870 | 0.030 |
Why?
|
Histiocytes | 1 | 2013 | 98 | 0.030 |
Why?
|
Hepatocyte Growth Factor | 1 | 2014 | 270 | 0.030 |
Why?
|
Proteins | 2 | 2004 | 6033 | 0.030 |
Why?
|
Giant Cells | 1 | 2013 | 188 | 0.030 |
Why?
|
In Situ Hybridization | 1 | 2016 | 1900 | 0.030 |
Why?
|
Lymphocyte Count | 1 | 2014 | 778 | 0.020 |
Why?
|
Colorectal Neoplasms | 1 | 2012 | 6894 | 0.020 |
Why?
|
Immunoblotting | 1 | 2015 | 1647 | 0.020 |
Why?
|
HT29 Cells | 1 | 2012 | 192 | 0.020 |
Why?
|
Receptors, Chemokine | 2 | 2006 | 653 | 0.020 |
Why?
|
Eye Movements | 1 | 1975 | 509 | 0.020 |
Why?
|
Mycological Typing Techniques | 1 | 2011 | 10 | 0.020 |
Why?
|
Chromatography, Liquid | 1 | 2015 | 983 | 0.020 |
Why?
|
DNA, Ribosomal Spacer | 1 | 2011 | 28 | 0.020 |
Why?
|
Drug Synergism | 1 | 2015 | 1755 | 0.020 |
Why?
|
Severity of Illness Index | 1 | 2009 | 15820 | 0.020 |
Why?
|
Microfluidic Analytical Techniques | 1 | 2017 | 803 | 0.020 |
Why?
|
Anilides | 1 | 2014 | 409 | 0.020 |
Why?
|
Benzenesulfonates | 1 | 2011 | 166 | 0.020 |
Why?
|
Survival Analysis | 2 | 2020 | 10075 | 0.020 |
Why?
|
Pyridines | 2 | 2014 | 2868 | 0.020 |
Why?
|
Mice | 5 | 2017 | 81402 | 0.020 |
Why?
|
Cytokines | 2 | 2017 | 7377 | 0.020 |
Why?
|
Diagnostic Techniques, Ophthalmological | 1 | 2013 | 251 | 0.020 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2013 | 614 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-kit | 1 | 2014 | 727 | 0.020 |
Why?
|
Lung | 1 | 2009 | 9973 | 0.020 |
Why?
|
Subcutaneous Tissue | 1 | 2011 | 132 | 0.020 |
Why?
|
Pyrimidinones | 1 | 2013 | 384 | 0.020 |
Why?
|
Cell Death | 1 | 2015 | 1664 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 2014 | 570 | 0.020 |
Why?
|
Cohort Studies | 3 | 2023 | 41366 | 0.020 |
Why?
|
Cell Culture Techniques | 1 | 2017 | 1667 | 0.020 |
Why?
|
Staining and Labeling | 1 | 2014 | 1083 | 0.020 |
Why?
|
High-Throughput Screening Assays | 1 | 2015 | 934 | 0.020 |
Why?
|
DNA, Fungal | 1 | 2011 | 275 | 0.020 |
Why?
|
Signal Transduction | 2 | 2010 | 23397 | 0.020 |
Why?
|
Quinazolines | 1 | 2015 | 1371 | 0.020 |
Why?
|
Benzimidazoles | 1 | 2014 | 855 | 0.020 |
Why?
|
Dogs | 1 | 2013 | 3839 | 0.020 |
Why?
|
Triazoles | 1 | 2014 | 903 | 0.020 |
Why?
|
Quinolines | 1 | 2014 | 764 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 2013 | 2468 | 0.020 |
Why?
|
Prednisone | 1 | 2013 | 1564 | 0.020 |
Why?
|
Reference Standards | 1 | 2012 | 1004 | 0.020 |
Why?
|
Treatment Outcome | 5 | 2015 | 64591 | 0.020 |
Why?
|
Debridement | 1 | 2011 | 493 | 0.020 |
Why?
|
Receptors, Natural Killer Cell | 1 | 2007 | 57 | 0.020 |
Why?
|
Eye | 1 | 2012 | 710 | 0.020 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2011 | 696 | 0.020 |
Why?
|
Hyperplasia | 1 | 2011 | 1153 | 0.020 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily K | 1 | 2007 | 95 | 0.020 |
Why?
|
Pyridones | 1 | 2013 | 807 | 0.020 |
Why?
|
Transfection | 1 | 2015 | 5776 | 0.020 |
Why?
|
Neoplasm Proteins | 2 | 2013 | 3610 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2016 | 6086 | 0.020 |
Why?
|
Genetic Testing | 1 | 2020 | 3535 | 0.020 |
Why?
|
Immunotherapy | 1 | 2002 | 4649 | 0.020 |
Why?
|
Biological Specimen Banks | 1 | 2012 | 782 | 0.020 |
Why?
|
Brain | 1 | 2013 | 27060 | 0.020 |
Why?
|
Cell Nucleus | 1 | 2015 | 2906 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2015 | 3428 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor C | 1 | 2006 | 127 | 0.020 |
Why?
|
Microscopy, Video | 1 | 2006 | 242 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 4567 | 0.020 |
Why?
|
Repressor Proteins | 1 | 2016 | 2978 | 0.020 |
Why?
|
Blotting, Western | 1 | 2013 | 5031 | 0.020 |
Why?
|
Swine | 1 | 2015 | 5915 | 0.020 |
Why?
|
Apoptotic Protease-Activating Factor 1 | 1 | 2004 | 22 | 0.020 |
Why?
|
Amidines | 1 | 2004 | 29 | 0.020 |
Why?
|
Diagnostic Errors | 1 | 2012 | 1264 | 0.010 |
Why?
|
Caspase 9 | 1 | 2004 | 185 | 0.010 |
Why?
|
Pedigree | 1 | 2012 | 4586 | 0.010 |
Why?
|
Clone Cells | 1 | 2007 | 1660 | 0.010 |
Why?
|
RNA, Messenger | 2 | 2013 | 12785 | 0.010 |
Why?
|
Glucocorticoids | 1 | 2013 | 2163 | 0.010 |
Why?
|
gp100 Melanoma Antigen | 1 | 2003 | 38 | 0.010 |
Why?
|
Benzylamines | 1 | 2004 | 247 | 0.010 |
Why?
|
MART-1 Antigen | 1 | 2003 | 65 | 0.010 |
Why?
|
Monophenol Monooxygenase | 1 | 2003 | 72 | 0.010 |
Why?
|
Health Care Surveys | 1 | 2010 | 2425 | 0.010 |
Why?
|
Receptors, CCR7 | 1 | 2003 | 107 | 0.010 |
Why?
|
Pore Forming Cytotoxic Proteins | 1 | 2003 | 133 | 0.010 |
Why?
|
Perforin | 1 | 2003 | 167 | 0.010 |
Why?
|
United States | 1 | 2011 | 72202 | 0.010 |
Why?
|
HLA-A2 Antigen | 1 | 2003 | 211 | 0.010 |
Why?
|
Cluster Analysis | 1 | 2009 | 2711 | 0.010 |
Why?
|
In Situ Nick-End Labeling | 1 | 2003 | 609 | 0.010 |
Why?
|
Follow-Up Studies | 2 | 2015 | 39078 | 0.010 |
Why?
|
Phosphorylation | 1 | 2013 | 8311 | 0.010 |
Why?
|
Ultrasonography | 1 | 2015 | 5966 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 2 | 2015 | 17854 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2014 | 10759 | 0.010 |
Why?
|
Granzymes | 1 | 2003 | 277 | 0.010 |
Why?
|
Risk Assessment | 2 | 2015 | 23953 | 0.010 |
Why?
|
Bayes Theorem | 1 | 2009 | 2326 | 0.010 |
Why?
|
Caspases | 1 | 2004 | 876 | 0.010 |
Why?
|
Camptothecin | 1 | 2004 | 590 | 0.010 |
Why?
|
Immunoenzyme Techniques | 1 | 2003 | 1704 | 0.010 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2011 | 2911 | 0.010 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2007 | 1649 | 0.010 |
Why?
|
Oncogenes | 1 | 2006 | 1223 | 0.010 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2014 | 3072 | 0.010 |
Why?
|
Terminology as Topic | 1 | 2007 | 1534 | 0.010 |
Why?
|
Survival Rate | 1 | 2014 | 12698 | 0.010 |
Why?
|
Academic Medical Centers | 1 | 2010 | 2757 | 0.010 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2011 | 1640 | 0.010 |
Why?
|
Epitopes, T-Lymphocyte | 1 | 2003 | 825 | 0.010 |
Why?
|
Referral and Consultation | 1 | 2012 | 3596 | 0.010 |
Why?
|
Immunoassay | 1 | 2002 | 746 | 0.010 |
Why?
|
Cytoskeleton | 1 | 2003 | 1167 | 0.010 |
Why?
|
Enzyme Activation | 1 | 2004 | 3592 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2014 | 14661 | 0.010 |
Why?
|
Histones | 1 | 2009 | 2577 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2014 | 18955 | 0.010 |
Why?
|
Serine Endopeptidases | 1 | 2003 | 1021 | 0.010 |
Why?
|
Massachusetts | 1 | 2010 | 8826 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2015 | 22097 | 0.010 |
Why?
|
Protein Biosynthesis | 1 | 2004 | 2114 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 2014 | 9176 | 0.010 |
Why?
|
Genotype | 1 | 2011 | 12976 | 0.010 |
Why?
|
Remission Induction | 1 | 2002 | 2394 | 0.010 |
Why?
|
Attitude of Health Personnel | 1 | 2010 | 3880 | 0.010 |
Why?
|
Immunologic Memory | 1 | 2003 | 1359 | 0.010 |
Why?
|
Killer Cells, Natural | 1 | 2005 | 2202 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2014 | 22121 | 0.010 |
Why?
|
Prevalence | 1 | 2011 | 15698 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2013 | 18216 | 0.010 |
Why?
|
Transcription Factors | 1 | 2014 | 12121 | 0.010 |
Why?
|
Pyrazoles | 1 | 2004 | 2007 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2009 | 9410 | 0.010 |
Why?
|
Membrane Glycoproteins | 1 | 2003 | 3701 | 0.010 |
Why?
|
Peptide Fragments | 1 | 2003 | 5105 | 0.010 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2003 | 4369 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2003 | 11526 | 0.000 |
Why?
|
Lung Neoplasms | 1 | 2006 | 13312 | 0.000 |
Why?
|
Prostatic Neoplasms | 1 | 2001 | 11095 | 0.000 |
Why?
|